C O V E R S T O R Y

Striking back

Will big pharma’s antidote to the COVID-19 waiver work?

Chinese remedy

What changes to China’s patent laws mean for life sciences

Mexico’s new IP regime

Will there be hurdles for plant owners?

NHS v Servier

Why the legal saga rumbles on

Exceptions in the UK

The low-down on experimental use exemptions

and much more…

ACCESS THE ISSUE >>